An aerogel that includes an open-cell structure and a polymer matrix is disclosed. The polymer matrix can include a branched polyimide polymer having a degree of branching of at least 0.5. The polymer matrix can contain less than 5% by weight of crosslinked polymers.

Aerogel compositions, methods for preparing the aerogel compositions, articles of manufacture that include or are made from the aerogel compositions are described and uses thereof. The aerogels include a branched polyimide matrix with little to no crosslinked polymers.

The invention is directed to biomedical polyurethanes. The invention is particularly directed to biomedical polyurethanes with improved biodegradability and to an improved preparation of the biomedical polyurethanes. In particular the present invention provides a biomedical polyurethane having the formula (A-B-C-B).sub.n, wherein A denotes a polyol, B denotes a diisocyanate moiety, C denotes a diol component and n denotes the number of recurring units, and wherein the B-C-B segment is bioresorbable.

Thermally treated aerogel compositions that include polyamic amides in an amount less than the aerogel compositions that include polyamic amides prior to thermal treatment, and articles of manufacture that include or are manufactured from the aerogel compositions are described.

The present disclosure is directed to methods of forming polyimide gels. The methods generally include forming a polyamic acid and dehydrating the polyamic acid with a dehydrating agent in the presence of water. The resulting polyimide gels may be converted to polyimide or carbon xerogels or aerogels. The methods are advantageous in providing rapid or even instantaneous gelation, which may be particularly useful in formation of beads comprising the polyimide gels. Polyimide or carbon gel materials prepared according to the disclosed method are suitable for use in environments containing electrochemical reactions, for example as an electrode material within a lithium-ion battery.

Systems and methods for producing aerogel materials are generally described. In certain cases, the methods do not require supercritical drying as part of the manufacturing process. In some cases, certain combinations of materials, solvents, and/or processing steps may be synergistically employed so as to enable manufacture of large (e.g., meter-scale), substantially crack free, and/or mechanically strong aerogel materials.

An aerogel that includes an open-cell structured polymer matrix is disclosed. The aerogel includes 5 wt. % to 50 wt. % of a polyamic amide polymer, based on the total weight of the aerogel, pores and at least 90% of the pore volume of the aerogel is made up of macropores, a porosity of at least 50%, as measure according to ASTM D4404-10, a density of 0.01 g/cm.sup.3 to 0.5 g/cm.sup.3, and the aerogel is thermally stable to resist browning at 330? C.

Absorbable medical devices based on novel foams and films made from semi-crystalline, segmented copolymers of lactide and epsilon-caprolactone exhibiting long term absorption characteristics are disclosed. Also disclosed are methods of producing said foams and films, and useful polymer solutions.

An aerogel comprising an open-cell structured polymer matrix that includes a polyamic amide polymer is described.

A method of making an aerogel is described. The method can include obtaining a solution comprising polyamic acid and an imidazole, adding a dehydrating agent to the solution in an amount where the molar ratio of the imidazole to the dehydrating agent is 0.17:1 to 2.8:1 and reacting the solution at room temperature to 100? C. to produce a polymer matrix gel comprising a polyamic amide, and drying the polymer matrix gel to form an aerogel comprising an open-cell structured polymer matrix that includes 5 wt. % to 50 wt. % of the polyamic amide based on the total weight of the polymer aerogel.